Madrigal Pharmaceuticals Inc (MDGL)

Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	18.92% 117.18	98.53	86.45	78.34	85.30
Interest Income/Expense	13.33% 3.971	3.504	2.901	2.336	1.682
Operating Income/Loss	18.92% -117.18	-98.53	-86.45	-78.34	-85.30
Income/Loss From Continuing Operations Before Tax	13.63% -112.19	-98.74	-85.80	-76.90	-85.91
Income/Loss From Continuing Operations After Tax	13.63% -112.19	-98.74	-85.80	-76.90	-85.91
Net Income/Loss	13.63% -112.19	-98.74	-85.80	-76.90	-85.91
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6.95% 19.76	18.48	18.31	18.19	17.24
Diluted Average Shares	6.95% 19.76	18.48	18.31	18.19	17.24
Basic Earnings Per Share	6.37% -5.68	-5.34	-4.69	-4.23	-4.98
Diluted Earnings Per Share	6.37% -5.68	-5.34	-4.69	-4.23	-4.98
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-